PDCD1 and breast neoplasm: Although transcriptomic studies have provided insight into the immune composition of both treatment naïve and anti-PD1 treated breast tumors at the single cell level15,27,28, a more systematic analysis of TIMEs with and without evidence of T cell exhaustion is missing.